glutathione synthetase deficiency prevalence dysregulation and the etiology and progression of human diseases Multiple congenital anomalies in two

In the studies that proofed tumor growth inhibition by a KD fed ad libitum, there was a significant increase in KB levels, but not necessarily decreases in blood glucose levels or body weight

Additionally, a significant association was observed between NAFLD and calcified coronary plaques (RR: 1.55, 95% CI: 1.05, 2.27)

[1] What the best bioavailability trial actually showed The most rigorous test of this question was a six-month, randomized, double-blind, placebo-controlled trial of oral glutathione at 250 or 1000 mg/day in 54 non-smoking adults

A compound can be widely discussed and still rest almost entirely on cell-culture and animal data, with little or no controlled human evidence